annual EBITDA:
$38.14M+$83.16M(+184.71%)Summary
- As of today (September 1, 2025), CSTL annual EBITDA is $38.14 million, with the most recent change of +$83.16 million (+184.71%) on December 31, 2024.
- During the last 3 years, CSTL annual EBITDA has risen by +$74.74 million (+204.19%).
- CSTL annual EBITDA is now at all-time high.
Performance
CSTL EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$3.29M-$218.00K(-6.21%)Summary
- As of today (September 1, 2025), CSTL quarterly EBITDA is $3.29 million, with the most recent change of -$218.00 thousand (-6.21%) on June 30, 2025.
- Over the past year, CSTL quarterly EBITDA has dropped by -$8.21 million (-71.38%).
- CSTL quarterly EBITDA is now -76.05% below its all-time high of $13.74 million, reached on December 31, 2024.
Performance
CSTL quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$32.57M-$8.21M(-20.14%)Summary
- As of today (September 1, 2025), CSTL TTM EBITDA is $32.57 million, with the most recent change of -$8.21 million (-20.14%) on June 30, 2025.
- Over the past year, CSTL TTM EBITDA has increased by +$23.21 million (+248.09%).
- CSTL TTM EBITDA is now -20.14% below its all-time high of $40.78 million, reached on March 31, 2025.
Performance
CSTL TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CSTL EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +184.7% | -71.4% | +248.1% |
| 3 y3 years | +204.2% | +438.3% | +168.3% |
| 5 y5 years | +271.1% | +751.9% | +197.7% |
CSTL EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +165.4% | -76.0% | +112.5% | -20.1% | +142.3% |
| 5 y | 5-year | at high | +165.4% | -76.0% | +112.5% | -20.1% | +142.3% |
| alltime | all time | at high | +165.4% | -76.0% | +112.5% | -20.1% | +142.3% |
CSTL EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $3.29M(-6.2%) | $32.57M(-20.1%) |
| Mar 2025 | - | $3.51M(-74.5%) | $40.78M(+6.9%) |
| Dec 2024 | $38.14M(-184.7%) | $13.74M(+14.3%) | $38.14M(+52.1%) |
| Sep 2024 | - | $12.02M(+4.5%) | $25.08M(+168.0%) |
| Jun 2024 | - | $11.50M(+1229.9%) | $9.36M(-152.4%) |
| Mar 2024 | - | $865.00K(+26.3%) | -$17.86M(-60.3%) |
| Dec 2023 | -$45.02M(-22.8%) | $685.00K(-118.5%) | -$45.02M(-29.0%) |
| Sep 2023 | - | -$3.70M(-76.5%) | -$63.42M(-17.7%) |
| Jun 2023 | - | -$15.72M(-40.2%) | -$77.05M(+23.7%) |
| Mar 2023 | - | -$26.29M(+48.4%) | -$62.30M(+6.8%) |
| Dec 2022 | -$58.34M(+59.4%) | -$17.72M(+2.3%) | -$58.34M(+7.4%) |
| Sep 2022 | - | -$17.32M(+1680.1%) | -$54.33M(+13.9%) |
| Jun 2022 | - | -$973.00K(-95.6%) | -$47.71M(-13.1%) |
| Mar 2022 | - | -$22.34M(+63.0%) | -$54.89M(+50.0%) |
| Dec 2021 | -$36.60M | -$13.70M(+28.0%) | -$36.60M(+34.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$10.70M(+31.3%) | -$27.15M(+34.3%) |
| Jun 2021 | - | -$8.15M(+101.4%) | -$20.21M(+60.9%) |
| Mar 2021 | - | -$4.05M(-4.8%) | -$12.57M(+77.1%) |
| Dec 2020 | -$7.09M(-169.0%) | -$4.25M(+12.9%) | -$7.09M(-4861.1%) |
| Sep 2020 | - | -$3.76M(+645.3%) | $149.00K(-98.6%) |
| Jun 2020 | - | -$505.00K(-135.4%) | $10.94M(-8.5%) |
| Mar 2020 | - | $1.43M(-52.4%) | $11.96M(+16.3%) |
| Dec 2019 | $10.28M(-373.3%) | $2.99M(-57.4%) | $10.28M(-13.6%) |
| Sep 2019 | - | $7.03M(+1275.3%) | $11.89M(+144.5%) |
| Jun 2019 | - | $511.00K(-301.2%) | $4.86M(+169.7%) |
| Mar 2019 | - | -$254.00K(-105.5%) | $1.80M(-287.2%) |
| Dec 2018 | -$3.76M(-63.8%) | $4.61M(-280.7%) | -$963.10K(-82.7%) |
| Jun 2018 | - | -$2.55M(-15.6%) | -$5.57M(+84.4%) |
| Mar 2018 | - | -$3.02M | -$3.02M |
| Dec 2017 | -$10.40M | - | - |
FAQ
- What is Castle Biosciences, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Castle Biosciences, Inc.?
- What is Castle Biosciences, Inc. annual EBITDA year-on-year change?
- What is Castle Biosciences, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Castle Biosciences, Inc.?
- What is Castle Biosciences, Inc. quarterly EBITDA year-on-year change?
- What is Castle Biosciences, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Castle Biosciences, Inc.?
- What is Castle Biosciences, Inc. TTM EBITDA year-on-year change?
What is Castle Biosciences, Inc. annual EBITDA?
The current annual EBITDA of CSTL is $38.14M
What is the all time high annual EBITDA for Castle Biosciences, Inc.?
Castle Biosciences, Inc. all-time high annual EBITDA is $38.14M
What is Castle Biosciences, Inc. annual EBITDA year-on-year change?
Over the past year, CSTL annual EBITDA has changed by +$83.16M (+184.71%)
What is Castle Biosciences, Inc. quarterly EBITDA?
The current quarterly EBITDA of CSTL is $3.29M
What is the all time high quarterly EBITDA for Castle Biosciences, Inc.?
Castle Biosciences, Inc. all-time high quarterly EBITDA is $13.74M
What is Castle Biosciences, Inc. quarterly EBITDA year-on-year change?
Over the past year, CSTL quarterly EBITDA has changed by -$8.21M (-71.38%)
What is Castle Biosciences, Inc. TTM EBITDA?
The current TTM EBITDA of CSTL is $32.57M
What is the all time high TTM EBITDA for Castle Biosciences, Inc.?
Castle Biosciences, Inc. all-time high TTM EBITDA is $40.78M
What is Castle Biosciences, Inc. TTM EBITDA year-on-year change?
Over the past year, CSTL TTM EBITDA has changed by +$23.21M (+248.09%)